|
Understanding the Data
RMA of New York reports its success rates annually to both the Society for
Assisted Reproductive Technology (SART), a professional organization dedicated
to maintaining the integrity of the practice of reproductive medicine in the
United States, and the Center for Disease Control and Prevention (CDC). In order
to assure that success rate calculations most accurately reflect center
experience, SART has specific guidelines to be followed when publicizing success
rates. RMA of New York is in full compliance with these guidelines.
The bars above show live birth outcomes for women who have initiated an IVF
cycle, egg retrieval, and embryo transfer, respectively, from January 1, 2002 to
December 31, 2007. Not all patients who begin a cycle undergo an egg retrieval
or transfer.
Important note: A comparison of clinic success rates may not be
meaningful because patient medical characteristics, treatment approaches and
entrance criteria for ART may vary from clinic to clinic.
FAQ:
According to SART, what constitutes a pregnancy?
A pregnancy can only be reported after a heartbeat is detected.
Why is 2007 the most recent data available?
Clinics must wait until they receive notification of every single birth
from the reporting year before they can submit all data; this means that for
2007, clinics had to wait to at least September of 2008 to compile all live
birth data. Once the data is submitted, checked and verified for accuracy, it
can then be published on the SART website or CDC website. This process takes
several months.
Where can I view RMA of New York’s complete success rates report?
You can access the rates by visiting CDC’s
website or SART’s
website.
|